Lista de obras - Elma Klein Kranenbarg - Dominio Público Uruguay

Accuracy of MRI for treatment response assessment after taxane- and anthracycline-based neoadjuvant chemotherapy in HER2-negative breast cancer

artículo científico publicado en 2014

Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01).

artículo científico publicado en 2014

An increasing use of defunctioning stomas after low anterior resection for rectal cancer. Is this the way to go?

artículo científico publicado en 2013

Bowel function 14 years after preoperative short-course radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomized trial.

artículo científico publicado en 2014

Breast Cancer Index predicts extended endocrine benefit to individualize selection of HR+ early stage breast cancer patients for 10 years of endocrine therapy

artículo científico publicado en 2020

CYP2D6 genotype in relation to hot flashes as tamoxifen side effect in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial

Carcinoembryonic antigen (CEA) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial

artículo científico publicado en 2006

Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit.

artículo científico publicado en 2002

Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch Colorectal Cancer Group

artículo científico publicado en 2003

Dynamic prediction in breast cancer: proving feasibility in clinical practice using the TEAM trial

artículo científico publicado en 2015

Efficacy of six month neoadjuvant endocrine therapy in postmenopausal, hormone receptor-positive breast cancer patients – A phase II trial

artículo científico publicado en 2014

Estrogen Receptor Pathway Activity Score to Predict Clinical Response or Resistance to Neoadjuvant Endocrine Therapy in Primary Breast Cancer

artículo científico publicado en 2019

Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial

artículo científico publicado en 2011

Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial

artículo científico publicado en 2020

Germline variants in the CYP19A1 gene are related to specific adverse events in aromatase inhibitor users: a substudy of Dutch patients in the TEAM trial

article

High non-compliance in the use of letrozole after 2.5 years of extended adjuvant endocrine therapy. Results from the IDEAL randomized trial

artículo científico publicado en 2011

Identification of a quantitative MINT locus methylation profile predicting local regional recurrence of rectal cancer.

artículo científico publicado en 2010

Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial

artículo científico publicado en 2005

Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer

artículo científico publicado en 2010

Improved overall survival for patients with rectal cancer since 1990: The effects of TME surgery and pre-operative radiotherapy

artículo científico publicado en 2008

Improved survival after resectable non-cardia gastric cancer in the Netherlands: The importance of surgical training and quality control

artículo científico publicado en 2009

Improvement of staging by combining tumor and treatment parameters: the value for prognostication in rectal cancer.

artículo científico publicado en 2007

Long term effects of extended adjuvant endocrine therapy on quality of life in breast cancer patients

artículo científico publicado en 2015

Losses of chromosome 5q and 14q are associated with favorable clinical outcome of patients with gastric cancer

artículo científico publicado en 2012

No Increased Risk of Second Cancer After Radiotherapy in Patients Treated for Rectal or Endometrial Cancer in the Randomized TME, PORTEC-1, and PORTEC-2 Trials

artículo científico publicado en 2014

No downstaging after short-term preoperative radiotherapy in rectal cancer patients

artículo científico publicado en 2001

Pathology data in the central databases of multicenter randomized trials need to be based on pathology reports and controlled by trained quality managers

artículo científico publicado en 2000

Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial

artículo científico publicado en 2009

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial

artículo científico publicado en 2011

Relationship between specific adverse events and efficacy of exemestane therapy in early postmenopausal breast cancer patients

scientific article published on 02 August 2012

Risk factors for sexual dysfunction after rectal cancer treatment

artículo científico publicado en 2009

Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer

artículo científico publicado en 2002

Surgical treatment of gastric cancer.

artículo científico publicado en 2000

Surgical trials in oncology. the importance of quality control in the TME trial

artículo científico publicado en 2002

Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01).

artículo científico publicado en 2015

Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intention

artículo científico publicado en 2009

Uniform Noting for International Application of the Tumor-Stroma Ratio as an Easy Diagnostic Tool: Protocol for a Multicenter Prospective Cohort Study

scientific article published on 14 June 2019

Validation of a nomogram for predicting disease-specific survival after an R0 resection for gastric carcinoma.

artículo científico publicado en 2005

White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer

scientific article published on 27 January 2020

Lista de obras de Elma Klein Kranenbarg

Accuracy of MRI for treatment response assessment after taxane- and anthracycline-based neoadjuvant chemotherapy in HER2-negative breast cancer

Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01).

An increasing use of defunctioning stomas after low anterior resection for rectal cancer. Is this the way to go?

Bowel function 14 years after preoperative short-course radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomized trial.

Breast Cancer Index predicts extended endocrine benefit to individualize selection of HR+ early stage breast cancer patients for 10 years of endocrine therapy

CYP2D6 genotype in relation to hot flashes as tamoxifen side effect in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial

Carcinoembryonic antigen (CEA) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial

Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit.

Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch Colorectal Cancer Group

Dynamic prediction in breast cancer: proving feasibility in clinical practice using the TEAM trial

Efficacy of six month neoadjuvant endocrine therapy in postmenopausal, hormone receptor-positive breast cancer patients – A phase II trial

Estrogen Receptor Pathway Activity Score to Predict Clinical Response or Resistance to Neoadjuvant Endocrine Therapy in Primary Breast Cancer

Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial

Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial

Germline variants in the CYP19A1 gene are related to specific adverse events in aromatase inhibitor users: a substudy of Dutch patients in the TEAM trial

High non-compliance in the use of letrozole after 2.5 years of extended adjuvant endocrine therapy. Results from the IDEAL randomized trial

Identification of a quantitative MINT locus methylation profile predicting local regional recurrence of rectal cancer.

Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial

Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer

Improved overall survival for patients with rectal cancer since 1990: The effects of TME surgery and pre-operative radiotherapy

Improved survival after resectable non-cardia gastric cancer in the Netherlands: The importance of surgical training and quality control

Improvement of staging by combining tumor and treatment parameters: the value for prognostication in rectal cancer.

Long term effects of extended adjuvant endocrine therapy on quality of life in breast cancer patients

Losses of chromosome 5q and 14q are associated with favorable clinical outcome of patients with gastric cancer

No Increased Risk of Second Cancer After Radiotherapy in Patients Treated for Rectal or Endometrial Cancer in the Randomized TME, PORTEC-1, and PORTEC-2 Trials

No downstaging after short-term preoperative radiotherapy in rectal cancer patients

Pathology data in the central databases of multicenter randomized trials need to be based on pathology reports and controlled by trained quality managers

Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial

Relationship between specific adverse events and efficacy of exemestane therapy in early postmenopausal breast cancer patients

Risk factors for sexual dysfunction after rectal cancer treatment

Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer

Surgical treatment of gastric cancer.

Surgical trials in oncology. the importance of quality control in the TME trial

Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01).

Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intention

Uniform Noting for International Application of the Tumor-Stroma Ratio as an Easy Diagnostic Tool: Protocol for a Multicenter Prospective Cohort Study

Validation of a nomogram for predicting disease-specific survival after an R0 resection for gastric carcinoma.

White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer